CRP and rheumatoid arthritis: The initiation of treatment for RA hinges on several critical factors, including the specific joints affected, the duration of symptoms, and the results of laboratory tests, which typically include rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies in conjunction with erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels [7,8].